Skip to main content

Table 4 Prognostic markers involved in regulating cell apoptosis in ESCC as reported in original studies

From: Immunohistochemical prognostic markers of esophageal squamous cell carcinoma: a systematic review

Marker

References

Sample size

Clinical stage

OS

DFS

Analytic methods

HR

95% CI

P value

HR

95% CI

P value

MDM2

Mathew et al. [11]

50

I–IV

–

–

>0.05

–

–

–

Log-rank test

Okamoto et al. [20]

86

I–IV

–

–

0.31

–

–

0.61

Log-rank test

Nam et al. [49]

51

I–IV

–

–

>0.05

–

–

–

Log-rank test

Ikeguchi et al. [55]

107

I–IV

2.017

1.098–3.703

0.024

–

–

–

Cox proportional hazards model

Sun et al. [56]

149

I–IV

1.698

1.054–

0.03

–

–

–

Cox proportional hazards model

Cheng et al. [57]

119

I–IV

0.168

0.533–1.509

0.682

–

–

–

Cox proportional hazards model

Fas

Chan et al. [60]

58

I–IV

0.639

0.442–0.925

<0.05

–

–

–

Cox proportional hazards model

Shibakita et al. [61]

106

I–IV

3.26

1.32–8.07

0.0103

–

–

–

Cox proportional hazards model

Chang et al. [62]

118

I–IV

–

–

>0.05

–

–

–

Log-rank test

Takikita et al. [63]

313

I–IV

0.79

0.49–1.27

0.32

–

–

–

Cox proportional hazards model

Bax

Ikeguchi et al. [13]

141

I–IV

–

–

>0.05

–

–

–

Cox proportional hazards model

Guner et al. [45]

53

I–IV

0.474

0.238–0.941

0.0328

–

–

–

Cox proportional hazards model

Chang et al. [62]

118

I–IV

–

–

>0.05

–

–

–

Cox proportional hazards model

Sturm et al. [64]

53

I–IV

0.435

0.242–0.862

0.016

–

–

–

Cox proportional hazards model

Kurabayashi et al. [65]

76

I–IV

–

–

<0.05

–

–

–

Log-rank test

Natsugoe et al. [66]

111

II–IV

–

–

>0.05

–

–

–

Log-rank test

Takayama et al. [67]

86

I–IV

0.954

0.517–1.763

0.881

–

–

–

Cox proportional hazards model

Matsumoto et al. [68]

79

–

–

–

>0.05

–

–

–

Cox proportional hazards model

Sarbia et al. [69]

172

I–IV

–

–

>0.05

–

–

–

Log-rank test

Bcl-2

Guner et al. [45]

53

I–IV

1.280

0.688–2.382

0.4364

–

–

–

Cox proportional hazards model (univariate)

Chang et al. [62]

118

I–IV

0.529

0.387–0.978

0.042

–

–

–

Cox proportional hazards model

Takikita et al. [63]

313

I–IV

1.29

0.52–3.25

0.58

–

–

–

Cox proportional hazards model

Kurabayashi et al. [65]

76

I–IV

–

–

>0.05

–

–

–

Log-rank test

Takayama et al. [67]

86

I–IV

1.506

0728–3.115

0.269

–

–

–

Cox proportional hazards model

Bcl-x

Natsugoe et al. [66]

111

II–IV

–

–

>0.05

–

–

–

Log-rank test

Takayama et al. [67]

86

I–IV

2.441

1.139–5.232

0.022

–

–

–

Cox proportional hazards model

Matsumoto et al. [68]

79

–

–

–

0.194

–

–

–

Cox proportional hazards model

Torzewski et al. [70]

172

I–IV

–

–

>0.05

–

–

–

Cox proportional hazards model

Caspase-3

Jiang et al. [14]

64

I–III

–

–

0.007

–

–

–

Cox proportional hazards model

Wang et al. [21]

122

–

0.584

0.370–0.921

0.021

–

–

–

Cox proportional hazards model

Chang et al. [62]

118

I–IV

–

–

>0.05

–

–

–

Cox proportional hazards model

Kurabayashi et al. [65]

76

I–IV

–

–

>0.05

–

–

–

Log-rank test

  1. No original studies on the prognostic significance of Survivin in ESCC were reported after the meta-analyses. Therefore, Survivin is not listed
  2. ESCC esophageal squamous cell carcinoma, MDM2 murine double minute gene 2, OS overall survival, DFS disease-free survival, HR hazard ratio, CI confidence interval, – no data